Skip to main content

Table 2 Initial findings on CMR

From: Cardiovascular magnetic resonance predictors of clinical outcome in patients with suspected acute myocarditis

LVEF at diagnosis, % 57.0 ± 9.0
LVEDV at diagnosis, ml/m2 72.9 ± 18.0
Patients with pericardial effusion (N,%) 58 (28.4)
Patients with asynergic myocardial segments (N,%) 39 (19)
LGE  
Number of patients with LGE (N,%) 203 (100)
Number of segments with LGE, N 3.8 ± 2.2
Myocardial extent of LGE (% myocardial surface area) 11.4 ± 7.0
Nodular Pattern (N,%) 150 (73.5)
Sub-epicardial lesions (N,%) 168 (82.3)
Midwall lesions (N,%) 33 (16.1)
Transmural lesions (N,%) 2 (1.0)
Presence of LGE in opposed walls (N,%) 77 (38.0)
Postero-lateral localization (N,%) 122 (60)
Anterior wall involved (N,%) 17 (8.3)
Postero-lateral and septal localisation (N,%) 60 (29.4)
Hyper T2 signal  
Number of patients with hyper T2 (N,%) 100 (62.5)
Number of segments with hyper T2 signal 1.9 ± 1.8
Myocardial extent of Hyper T2 (% myocardial surface area) 10.9 ± 5.7
Presence of T2 hyper-signal in opposed walls (N,%) 34 (21.2)
EGE  
Number of patients with EGE (N,%) 114 (56)
Number of segments with EGE 1.8 ± 1.9
Myocardial extent of EGE (% myocardial surface area) 8.6 ± 5.4
Presence of local EGE in opposed walls (N,%) 30 (14.7)
  1. Values are expressed as mean ± SD unless specified